Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary
The DOI matches its Crossref record; 299 of the 300 references it cites were found in a registry or an index.
Abstract
Abbreviations: A1C = hemoglobin A1C; AACE = American Association of Clinical Endocrinologists; ABCD = adiposity-based chronic disease; ACCORD = Action to Control Cardiovascular Risk in Diabetes; ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure; ACE = American College of Endocrinology; ACEI = angiotensin-converting enzyme inhibitor; AGI = alpha-glucosidase inhibitor; apo B = apolipoprotein B; ARB = angiotensin II receptor blocker; ASCVD = atherosclerotic cardiovascular disease; BAS = bile acid sequestrant; BMI = body mass index; BP = blood pressure; CCB = calcium channel blocker; CGM = continuous glucose monitoring; CHD = coronary heart disease; CKD = chronic kidney disease; DKA = diabetic ketoacidosis; DPP4 = dipeptidyl peptidase 4; eGFR = estimated glomerular filtration rate; EPA = eicosapentaenoic acid; ER = extended release; FDA = Food and Drug Administration; GLP1 = glucagon-like peptide 1; HDL-C = high-density-lipoprotein cholesterol; HeFH = heterozygous familial hypercholesterolemia; LDL-C = low-density-lipoprotein cholesterol; LDL-P = low-density-lipoprotein particle; Look AHEAD = Look Action for Health in Diabetes; NPH = neutral protamine Hagedorn; OSA = obstructive sleep apnea; PCSK9 = proprotein convertase subtilisin-kexin type 9 serine protease; RCT = randomized controlled trial; SU = sulfonylurea; SGLT2 = sodium-glucose cotransporter 2; SMBG = self-monitoring of blood glucose; T2D = type 2 diabetes; TZD = thiazolidinedione.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiologic evidence shows a continuous relationship between A1C and CVD and all-cause mortality.72”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [72]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Cited by
Items 501–600 of 610
Gagner, M. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05637-x
“My letter to the editor did not concern this specific aspect [2], but rather was a rebuttal to the Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2020 executive summary, who keep procrastinatin…”
BackgroundA Rock-Solid Case for Continuous Glucose Monitors
Ekenga, V. (2021) · ADCES in Practice · doi:10.1177/2633559x211034486
Metformin: We need to either put it in our drinking water or rethink how we study itPreprint
Powell, M. A., Clark, C. N., Alyakin, A., Vogelstein, J. T., & Hart, B. (2021) · medRxiv · doi:10.1101/2021.09.15.21263634
Corsino, L., & Mcneill, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-75377-1_17
Evolution of Glycemic Targets in Management of Diabetes
Masood, M. Q. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115018
Dhingra, V., Jain, S., Kant, R., & Kumari, R. (2021) · World Journal of Nuclear Medicine · doi:10.4103/wjnm.wjnm_112_20 · Cited by 1
Li, Q., Zhang, Q., Wang, R., & Hong, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01182-z
“In addition to the glucose-lowering and weight loss effects and low risk of hypoglycemia associated with dulaglutide that were supported by the present analysis, the primary and secondary cardiovascular benefits of dulaglutide [16] as well as frequency of administration and adherence are clinically relevant factors th…”
BackgroundOrthopaedic Nursing and Heart Failure
Kujath, A. S., & Frei, J. (2022) · Orthopaedic Nursing · doi:10.1097/nor.0000000000000818
Dib, A., Chartier, F., Ihle, K., Jamonneau, I., Ludwig, L., & Darmon, P. (2022) · Diabetes Therapy · doi:10.1007/s13300-021-01200-0
Pandya, N., & Patel, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-01782-8_38-1
Mak, M. (2020) · Online Journal of Cardiology Research & Reports · doi:10.33552/ojcrr.2020.04.000577
PREDIABETES – RISKS AND APPROACH FOR MANAGEMENT
Guha, M. K. (2021) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/3500371
Impact of Glucagon-Like Peptide 1 Receptor Agonists in Patients with Hemoglobin A1c of 9% or Greater
Tran, V., Tran, H., Demirel, S., & Thompson‐Moore, N. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221087933
Elmalti, A., Mukhtar, M., Skaria, S., & Harbagi, W. (2021) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.4103/ijmbs.ijmbs_3_21
Diagnosis and Management of Heart Disease
Stolker, J. M., & Rich, M. W. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.013
Antidiabetik Oral Kombinasi Penghambat DPP-4 dan Penghambat SGLT-2
Lukito, J. I. (2021) · Cermin Dunia Kedokteran · doi:10.55175/cdk.v48i12.157 · Cited by 4
Chirurgia bariatrica: focus sul ruolo dell’endocrinologo
Guarisco, G., Capoccia, D., & Leonetti, F. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01103-7
Nguyễn, X. T. (2022) · Tập san Khoa học và kỹ thuật trường Đại học Bình Dương · doi:10.56097/binhduonguniversityjournalofscienceandtechnology.v5i2.49
Singh, G., Krauthamer, M., & Bjalme-Evans, M. (2021) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20210604.17
Semaglutide: A Strategic Weapon for Primary Care
Jain, A. (2022) · The Singapore Family Physician · doi:10.33591/sfp.48.3.u3
Role of Ceramide in insulin resistance in type 2 diabetes.
Mohamed, M., Ahmed, Y. H., Al-Adl, H. A.-A., & abo-ghabha, M. E. (2022) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.21608/aimj.2022.126195.1872
Li, Y., Wu, Y. Y., Shu, Y., Li, S., Pei, J., Chen, H., Liu, S., Xiang, G., Wang, W., Shan, P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.998210
Geliebter, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-15353-2_7
Nasir, A., Rao, M., Mahmud, Q., Anwar, W., Kanwal, Z., & Asghar, A. (2023) · JAIMC Journal of Allama Iqbal Medical College · doi:10.59058/jaimc.v20i3.66
Anthamatten, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-20193-6_12
Sodium-glucose Co-transporter-2 inhibitors: a new era of cardioprotection and renoprotection
Balasubramanian, P., & Inzucchi, S. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00006-1 · Cited by 2
Whitley, H. P., & Smith, W. D. (2023) · Journal of Case Reports and Images in Medicine · doi:10.5348/100073z09hw2022cs · Cited by 1
Mora, S., & Martin, S. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00003-0
Managing Stable Coronary Artery Disease in Diabetes
Koulouridis, I., & Johnstone, M. T. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_23
Issues of insulin therapy for type 2 diabetes and ways to solve them
Katerenchuk, V. I., & Katerenchuk, A. V. (2023) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.19.3.2023.1277
Clinical Practice Guidelines, Evidence-Based Medicine and Diabetes
Rodríguez‐Saldaña, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_23
Mühlhauser, I., Buhse, S., & Rodríguez‐Saldaña, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_34
Wojciechowska, J. K., Krajewski, W. R., Zatoński, T., & Rodríguez‐Saldaña, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_63
Effects of a 12-week Plant-Based Diet Program on Obese and Overweight Adults in Rural Michigan
Larcher, N. (2023) · Digital Commons - Andrews University (Andrews University) · doi:10.32597/dnp/15/ · Cited by 1
Biomathematical Analysis on Impedance Measurement During COVID-19 Pandemic
Zhao, B. (2022) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2022.17.002360
Patient with newly diagnosed type 2 diabetes? Remember these steps
Jarrett, J. B. (2023) · The Journal of Family Practice · doi:10.12788/jfp.0608
Ganda, O. P., Busch, R. S., Nelson, J. R., & Philip, S. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_25
Minimizing Hypoglycemia with Insulin Therapy: The “THINK” Strategy
Priya, G., & Grewal, E. (2022) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_9_22
Delirio y Diabetes tipo 2: Revisión actualizada de su asociación fisiopatológica en la persona mayor
Moreira, H. R. R., Mejía, M. F. M., & Alencastro, J. A. P. (2023) · LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades · doi:10.56712/latam.v4i3.1110 · Cited by 1
Economic burden of hypercholesterolemia in high risk of cardiovascular disease population in Mexico
Gasca-Pineda, R., Osorio-Hernández, M., Mehta, R., Escobedo, J., & Narváez-Oríani, C. A. (2023) · Archivos de cardiolog�a de M�xico (English ed Internet) · doi:10.24875/acme.m22000411
Alicic, R. Z., Neumiller, J. J., & Tuttle, K. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00039-6
juan, H. W., jingjuan, X., yun, Y., Hao, X., Tang, Z., jiao, X., & minxing, Y. (2022) · PubMed · doi:10.2196/preprints.41274
Khan, P. M., Venkatesh, S., Parveen, R., Mishra, P., Jain, S., & Agarwal, N. B. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2279100
La oportunidad que supone disponer de un arGLP-1 oral
Orozco‐Beltrán, D. (2023) · Diabetes práctica · doi:10.52102/diabet/pract.manejointegral.art4
Problems and decisions in the management of type 2 diabetes mellitus: the role of metformin
Svetlova, O. V., Владимировна, Г. И., Kuzina, D. V., & Voronin, A. V. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-466
Shah, S. R., Sannan, D. M., Safdar, T., Bajwa, D. A. K., Ali, D. A., & Rehman, M. U. (2024) · doi:10.53555/jptcp.v31i3.4955
Park, S., Jeong, H. E., Oh, I., Hong, S., Yu, S. H., Lee, C. B., & Shin, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-077084
Park, S., Choi, W., Bae, D., Kim, M. H., Lee, J. H., Kim, S., Bae, J., Kim, D.-W., Cho, M., Kim, C.-J., et al. (2024) · Coronary Artery Disease · doi:10.1097/mca.0000000000001369
“Generally, intensive glucose control targeting glycated hemoglobin (HbA1c) levels of ≤6.5–7.0% is recommended; however, glycemic targets should be individualized considering hypoglycemia risk [7,8].”
InfluentialCetoacidose metabólica: condições clínicas e abordagens terapêuticas
Frazão, L. F. N., de Oliveira, J. M. G., Pereira, M. M., Ramos, J. L. B., dos Santos, D. R. L., Neto, O. B. D. O., Matos, J. P. A., Santos, T. G. D., dos Santos, M. M., dos Santos, G. D., et al. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n5p1035-1043
Berar, U., Kaur, P., & Raghav, N. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4830419
Cardiovascular Disease Risk and Risk Reduction Strategies in Diabetes Mellitus
Wilson, D. P., Hamilton, L., & Maki, K. C. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_14
Alanís, A. Y., Sánchez, O. D., Vaca-González, A., & Pérez‐Cisneros, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-44-322341-9.00010-0
Effective Management of Hypertension: A Cross-Sectional Study of Five Health FacilitiesPreprint
Antwi, S. A., Appiah, J. A., & Boateng, C. K. (2024) · Research Square · doi:10.21203/rs.3.rs-4471168/v1
Amin, H. H., & Chaudhary, H. R. (2024) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2024.160317
Супрун, О. Е., Bagriy, A. E., Михайличенко, Е. С., Andreeva, E. A., Yevtushenko, A. A., & Suprun, E. V. (2024) · Актуальные проблемы медицины · doi:10.52575/2687-0940-2024-47-1-14-26
Liu, Z., Chen, X., Zhao, H.-Y., Zhan, S., & Sun, F. (2024) · PubMed Central · doi:10.19723/j.issn.1671-167x.2024.03.008 · Cited by 1
Đinh, T. N. M., Trương, Q. H., & Lâm, V. N. (2024) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v540i3.10522
Indraswari, A. D. W., Yulia, Y., & Hariyati, R. T. S. (2024) · Journal of Telenursing (JOTING) · doi:10.31539/joting.v6i1.9253 · Cited by 1
Esaifan, H. A., Saadah, L. M., Hammour, K. A., & Farha, R. K. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309365
“The United States Food and Drug Administration (FDA) approved medications across diverse classes [4–6].”
BackgroundBal, O., Üstündağ, S., Akhan, L. U., TERKEŞ, N., Bayram, A. K., Karabulut, E., Boğan, F., & Şen, B. A. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3215
Abdullah, K., Elsharkawy, M. M., Issak, E. R., ElSerafy, A. S., Idris, S., Bendary, A., Badr, H. R., Shehata, M., & Reda, A. (2024) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2024.159026
Pump, Infusion Set, and Insulin Options and Selection
(2024) · American Diabetes Association eBooks · doi:10.2337/9781580408363.ch02
Arero, A. G., Rabizadeh, S., Sorato, M. M., AlJasem, M., Arero, G., Esteghamati, A., & Nakhjavani, M. (2024) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0044-1791692
Autismo, gestação e estilo de vida: uma revisão integrativa
Novaes, J. F. D. A., CARREIRO, G. F., Dias, A. K. F. D. M., da Mota, M. K. F., Souza, S. B. B., & Farias, T. M. (2024) · Brazilian Journal of Lifestyle Medicine = Revista Brasileira de Medicina do Estilo de Vida · doi:10.61661/bjlm.2024.v3.89 · Cited by 1
Khan, D., Khattak, L. Z., Faryal, S., DurreBeda, S., Shakeel, Z., Waqas, M., Ullah, N., Nazir, M., & Nazir, S. (2024) · Indus journal of bioscience research. · doi:10.70749/ijbr.v2i02.177
Clinical Sample Considerations in Proteomics-Based Biomarker Studies: Advancing Precision Medicine
Kachhawaha, K., Shah, R., & Singh, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-5045-0_2
Transforming Alzheimer's Treatment: Unveiling New Potential with Drug Repurposing Strategies
Mishra, A. S., Vasanthan, M. V. M., Ghosh, B., & Sivakumar, P. M. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673341391241231054936 · Cited by 2
Andersen, J. W., Høgh, A. L., Lindholt, J. S., Søgaard, R., Støvring, H., Yderstræde, K. B., Sandbæk, A., & Dahl, M. (2025) · Clinical Epidemiology · doi:10.2147/clep.s487825
Clinical pharmacist roles in a virtual continuous glucose monitor initiation service
Wettergreen, S. A., Sobczak, C., Jortberg, B. T., Oser, S. M., Buss, D., Parascando, J. A., Daffron, A., & Oser, T. K. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70046
(2025) · Texila international journal of academic research · doi:10.21522/tijar.2014.12.02.art012
Karlsen, M. C. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251328109
Cao, L., Chen, S., Xu, Q., Chen, C., Lv, Q., Li, X., & Li, X. (2025) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70049 · Cited by 1
SGLT2 Inhibitors: Increasing Benefits, Continued Concerns
Hernandez-Morgan, M., Disque, A. A., & Neelankavil, J. P. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.06.052
Majd, Z., Cheruvu, S. S., Chen, H., Johnson, M. L., Birtcher, K. K., Serna, O., & Abughosh, S. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2682989
Sun, R.-M., Dai, D.-X., Xu, F., Ling, Y., & Xie, Z. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i7.106470
Kamel, A. Y., Shah, P., Pipek, L. Z., Shah, A., & Kandiah, P. (2025) · Current Surgery Reports · doi:10.1007/s40137-025-00465-9
“Early identification of at-risk individuals, cautious reintroduction of nutrition and attentive electrolyte repletion are critical to avoiding life-threatening complications.”
Association of Circulatory T-cadherin with Diagnostic Parameters of Metabolic Syndrome
Khan, M. D., Ahmad, M. K., Khan, S., Alam, R., Singh, A., & Khan, M. M. (2025) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_500_24 · Cited by 1
Halver, A. (2025) · Federal Practitioner · doi:10.12788/fp.0642
“9,10 The additional reduction in daily insulin dose when continuing on semaglutide 2 mg for ≥ 3 months was an unanticipated but added benefit, showing that if tolerated, maintaining the 2-mg dose will help patients reduce their insulin doses.”
Whitley, H. P. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch14
Study of Antidiabetic Potential of Polyherbal Formulation
Varal Neeta., R., & Kiran.S, M. L. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-29960
Simonyan, M. A., Vasileva, V. A., Marchenkova, L., Александровна, К. А., & Kiyatkin, V. A. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-433
Liao, K. P., Rist, P. M., Giles, J., Santacroce, L. M., Connelly, M. A., Glynn, R. J., Ridker, P. M., Tawakol, A., Bathon, J., & Solomon, D. H. (2024) · Figshare · doi:10.6084/m9.figshare.26094432
Wong, C. K. H., Lau, K. T. K., Tang, E. H. M., Lee, C. H., Lee, C. Y. Y., Woo, Y. C., Au, I. C. H., Tan, K. C. B., & Lui, D. T. W. (2022) · Figshare · doi:10.6084/m9.figshare.20003398
Hyun, M. K., Lee, J. W., & Ko, S.-H. (2023) · Figshare · doi:10.6084/m9.figshare.23119010
Choi, I. J., Choo, E. H., Kim, H. J., Lim, S., Moon, D., Lee, K. Y., Hwang, B.-H., Kim, C. J., Park, M.-W., Lee, J.-M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17210668
Triadisti, N. (2025) · Journal of Innovation Research and Knowledge · doi:10.53625/jirk.v5i3.10878
Chun Kwan, O., Chan, R. N., Chan, K. P., Wu, H., Lam, F. M., Lee, H. H., Chow, E., Luk, A. O. Y., Ronald, C. W., Wing, Y. K., et al. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.12.003
Working Class Diabetes: The World Forgot
Mishra, A. B. (2025) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v6i12.2260
Arya, A., & Verma, A. R. (2026) · International Journal of Current Pharmaceutical Review and Research · doi:10.25258/ijcpr.18.2.19
“DPP-4 inhibitors provide favorable tolerability profiles suitable for elderly or frail patients [19].”
Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
Henson, J. J., Davies, M. J., Greaves, C., Khunti, K., & Yates, T. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00003-3
Yamauchi, K. (2026) · Cureus · doi:10.7759/cureus.106472
“Notably, the American Diabetes Association and the European Association for the Study of Diabetes do not define a strict plasma glucose threshold for the diagnosis of DKA [2,3].”
ЭФФЕКТИВНОСТЬ КОМПЛЕКСНОЙ ТЕРАПИИ И ПРОФИЛАКТИКИ НАРУШЕНИЙ ФУНКЦИИ ПОЧЕК ПРИ САХАРНОМ ДИАБЕТЕ 2 ТИПА
Дзугкоева, Ф. С., Дзугкоев, С. Г., Хубулова, А. Е., & Беленчеков, А. А. (2026) · Современные проблемы науки и образования · doi:10.17513/spno.34580
喻, 慧. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1651815
Patient Assessment for Bone Grafting Treatments in Oral and Maxillofacial Surgery
Shafiei, S., Alam, M. M. R., & Dastgir, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-36962-9_34-1
Buzek, E., Tomaszewska, A. J., Kaczmarek, M., Pojawa, M., Chudzik, A., Prządka, J., & Witkowska, W. (2026) · Quality in Sport · doi:10.12775/qs.2026.56.71975
Jiao, Y., & Ma, J. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm54062
Tang, W., Wei, L., Lu, W., You, Z., Chen, H. T., Sun, W., & Wu, H. Y. (2026) · BMC Health Services Research · doi:10.1186/s12913-026-14780-z
“Insulin degludec and insulin aspart, as a novel insulin analog, is favored by both physicians and patients for its dual-phase mechanism (addressing both basal and postprandial glucose control) and reduced injection frequency [45].”
Metadata
- Authors
- Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., Garvey, W. T., Hirsch, I. B., Jellinger, P. S., McGill, J. B., Mechanick, J. I., Perreault, L., Rosenblit, P. D., Samson, S., & Umpierrez, G. E.
- Affiliations
- Baylor College of Medicine (US)
- Oakland University (US)
- University of California San Diego (US)
- Beth Israel Deaconess Medical Center (US)
- Kaiser Permanente (US)
- Ochsner Health System (US)
- Cedars-Sinai Medical Center (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Alabama at Birmingham (US)
- University of Washington (US)
- University of Miami (US)
- Washington University in St. Louis (US)
- Icahn School of Medicine at Mount Sinai (US)
- University of Colorado Anschutz (US)
- University of California, Irvine (US)
- Emory University (US)
- ORCID
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 26
- Issue
- 1
- Pages
- 107-139
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W3004838676
- Cited by
- 598
- References
- 300
- Citations by year
- 2026: 21 · 2025: 41 · 2024: 80 · 2023: 104 · 2022: 146 · 2021: 125 · 2020: 81
- FWCI
- 85.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes management, glycemic control, cardiovascular risk, atherosclerotic cardiovascular disease, chronic kidney disease, diabetic ketoacidosis, obstructive sleep apnea, dyslipidemia, obesity, GLP-1 receptor agonists, SGLT2 inhibitors, insulin therapy, continuous glucose monitoring, self-monitoring of blood glucose
- MeSH terms
- Proprotein Convertase 9, Endocrinologists, Algorithms, Blood Glucose, Diabetes Mellitus, Type 2, Humans, United States, Blood Glucose Self-Monitoring, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.